NCODA Logo

FOR IMMEDIATE RELEASE
August 9th 2021

STATEMENT FROM NCODA Legislative & Policy Advisory Committee
Contact: Kevin Scorsone | NCODA Legislative & Policy Liaison
Phone: (919) 903-2057
Email: kevin.scorsone@ncoda.org
www.ncoda.org

BIDEN ADMINISTRATION PROPOSES WITHDRAW FROM MOST FAVORED NATION

 

NCODA has been in opposition of the Most Favored Nation (MFN) model for Medicare patients since it was announced late last year. The model would have negatively affected patient access to Part B drugs – the chemotherapy and infusion treatments that are administered in our community oncology practices. NCODA is thrilled to report that the MFN rule has been set for elimination by the Biden administration.

Late last week President Biden proposed the rule to rescind the Most Favored Nation Model interim final rule with comment period that appeared in the November 27, 2020 Federal Register. *

In a year that has been highlighted with substantial victories for the oncology community in various legislatures, this announcement is an exclamation point on the hard work that has been set forth to make quality care for all patients a reality.

NCODA will never support the implementation of a mandatory model on cancer patients and the oncology community. Not only would a mandatory model create a potentially insurmountable challenge for oncology practice it would hurt the people who matter most, the patient. Our Passion for Patients is not just a statement it continues to be our mission and focus.

* = Via the U.S. Department of Health and Human Services